COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?

Bibliographic Details
Main Authors:	Hyle, E.P (Author), Pandya, A. (Author), Persad, G. (Author), Sarpatwari, A. (Author)
Format:	Article
Language:	English
Published:	American College of Physicians 2022
Subjects:	ad26.cov2.s vaccine adult Adult biontech covid 19vaccine control strategy coronavirus disease 2019 cost benefit analysis COVID-19 COVID-19 testing COVID-19 Testing COVID-19 Vaccines diagnosis diagnostic error disease severity disease transmission drug cost Drug Costs economic development economic efficiency economic stability economics elasomeran health care access health care availability health care cost health care policy health promotion high risk patient human Humans Immunization, Secondary johnson and johnson covid 19vaccine moderna covid 19vaccine Note patient compliance prevention and control prophylaxis risk reduction safety SARS-CoV-2 vaccine secondary immunization severe acute respiratory syndrome coronavirus 2 vaccine booster tozinameran unclassified drug United States vaccination vaccination coverage
Online Access:	View Fulltext in Publisher

View Fulltext in Publisher

Similar Items